Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Regeneron Pharmaceuticals, Inc. REGN

Full chart Compare
Set alert

Price alert · REGN

All alert types
971.20 USD +9.94 (+1.03%)

Nov 3, 2026, 3:56 PM EST

953.00 Day range 975.49
600.66 52-week range 971.21
YTD
+25.82%
1 year
+51.22%

Financial health

Altman Z-Score

7.90 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

6 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

A4 / 5 overall

  • DCF 5
  • Return on Equity 4
  • Return on Assets 5
  • Debt / Equity 3
  • P/E 3
  • P/B 3

Valuation

P/E 17.9×
FY 2016: 42.9×FY 2017: 33.4×FY 2018: 17.5×FY 2019: 19.4×FY 2020: 14.8×FY 2021: 8.3×FY 2022: 17.8×FY 2023: 23.7×FY 2024: 17.4×FY 2025: 17.9×
FY 2016 5y median 17.8× FY 2025
P/S 5.6×
FY 2016: 8.8×FY 2017: 7.4×FY 2018: 6.4×FY 2019: 6.3×FY 2020: 6.1×FY 2021: 4.2×FY 2022: 6.3×FY 2023: 7.1×FY 2024: 5.4×FY 2025: 5.6×
FY 2016 5y median 5.6× FY 2025
P/B 2.6×
FY 2016: 9.6×FY 2017: 7.1×FY 2018: 4.9×FY 2019: 3.7×FY 2020: 4.7×FY 2021: 3.6×FY 2022: 3.4×FY 2023: 3.6×FY 2024: 2.6×FY 2025: 2.6×
FY 2016 5y median 3.4× FY 2025
P/FCF 19.8×
FY 2016: 43.8×FY 2017: 42.1×FY 2018: 23.7×FY 2019: 20.5×FY 2020: 25.9×FY 2021: 10.2×FY 2022: 17.5×FY 2023: 25.6×FY 2024: 21.0×FY 2025: 19.8×
FY 2016 5y median 19.8× FY 2025
EV/EBITDA 13.8×
FY 2016: 29.6×FY 2017: 19.3×FY 2018: 15.4×FY 2019: 15.0×FY 2020: 12.8×FY 2021: 6.9×FY 2022: 14.6×FY 2023: 20.0×FY 2024: 14.5×FY 2025: 13.8×
FY 2016 5y median 14.5× FY 2025
EV/Sales 5.6×
FY 2016: 8.8×FY 2017: 7.4×FY 2018: 6.3×FY 2019: 6.1×FY 2020: 6.2×FY 2021: 4.1×FY 2022: 6.3×FY 2023: 7.1×FY 2024: 5.4×FY 2025: 5.6×
FY 2016 5y median 5.6× FY 2025
FCF Yield 5.1%
FY 2016: 2.3%FY 2017: 2.4%FY 2018: 4.2%FY 2019: 4.9%FY 2020: 3.9%FY 2021: 9.8%FY 2022: 5.7%FY 2023: 3.9%FY 2024: 4.8%FY 2025: 5.1%
FY 2016 5y median 5.1% FY 2025

Profitability

Gross Margin 85.4%
FY 2016: 91.7%FY 2017: 90.8%FY 2018: 91.3%FY 2019: 85.1%FY 2020: 84.0%FY 2021: 83.1%FY 2022: 86.0%FY 2023: 82.9%FY 2024: 86.1%FY 2025: 85.4%
FY 2016 5y median 85.4% FY 2025
Operating Margin 24.9%
FY 2016: 27.4%FY 2017: 35.4%FY 2018: 37.8%FY 2019: 33.7%FY 2020: 42.1%FY 2021: 55.7%FY 2022: 44.2%FY 2023: 33.2%FY 2024: 28.1%FY 2025: 24.9%
FY 2016 5y median 33.2% FY 2025
Net Margin 31.4%
FY 2016: 18.4%FY 2017: 20.4%FY 2018: 36.4%FY 2019: 32.3%FY 2020: 41.3%FY 2021: 50.2%FY 2022: 35.6%FY 2023: 30.1%FY 2024: 31.1%FY 2025: 31.4%
FY 2016 5y median 31.4% FY 2025
ROE 14.4%
FY 2016: 20.1%FY 2017: 19.5%FY 2018: 27.9%FY 2019: 19.1%FY 2020: 31.9%FY 2021: 43.0%FY 2022: 19.1%FY 2023: 15.2%FY 2024: 15.0%FY 2025: 14.4%
FY 2016 5y median 15.2% FY 2025
ROIC 8.5%
FY 2016: 13.6%FY 2017: 13.5%FY 2018: 20.6%FY 2019: 15.1%FY 2020: 22.8%FY 2021: 34.9%FY 2022: 18.4%FY 2023: 13.8%FY 2024: 10.9%FY 2025: 8.5%
FY 2016 5y median 13.8% FY 2025
ROA 11.1%
FY 2016: 12.8%FY 2017: 13.7%FY 2018: 20.8%FY 2019: 14.3%FY 2020: 20.5%FY 2021: 31.7%FY 2022: 14.9%FY 2023: 12.0%FY 2024: 11.7%FY 2025: 11.1%
FY 2016 5y median 12.0% FY 2025

Growth (YoY)

Revenue 1.0%
FY 2016: 18.4%FY 2017: 20.8%FY 2018: 14.3%FY 2019: -2.3%FY 2020: 29.6%FY 2021: 89.1%FY 2022: -24.3%FY 2023: 7.8%FY 2024: 8.3%FY 2025: 1.0%
FY 2016 FY 2025
Operating Income -10.3%
FY 2016: 6.3%FY 2017: 56.3%FY 2018: 21.9%FY 2019: -12.8%FY 2020: 61.9%FY 2021: 150.1%FY 2022: -39.8%FY 2023: -19.3%FY 2024: -8.2%FY 2025: -10.3%
FY 2016 FY 2025
EPS (diluted) 8.2%
FY 2016: 39.5%FY 2017: 34.3%FY 2018: 105.9%FY 2019: -13.3%FY 2020: 65.3%FY 2021: 135.8%FY 2022: -46.9%FY 2023: -9.0%FY 2024: 10.3%FY 2025: 8.2%
FY 2016 FY 2025
Free Cash Flow 11.3%
FY 2016: 49.2%FY 2017: 6.2%FY 2018: 75.2%FY 2019: 10.4%FY 2020: 0.2%FY 2021: 225.9%FY 2022: -32.2%FY 2023: -17.1%FY 2024: -0.1%FY 2025: 11.3%
FY 2016 FY 2025

Financial Health

Current Ratio 4.1×
FY 2016: 3.2×FY 2017: 4.9×FY 2018: 5.5×FY 2019: 3.7×FY 2020: 3.6×FY 2021: 3.6×FY 2022: 5.1×FY 2023: 5.7×FY 2024: 4.7×FY 2025: 4.1×
FY 2016 5y median 4.7× FY 2025
Quick Ratio 3.4×
FY 2016: 2.8×FY 2017: 4.3×FY 2018: 4.7×FY 2019: 3.0×FY 2020: 2.9×FY 2021: 3.1×FY 2022: 4.3×FY 2023: 4.9×FY 2024: 3.9×FY 2025: 3.4×
FY 2016 5y median 3.9× FY 2025
Debt / Equity 0.1×
FY 2016: 0.1×FY 2017: 0.1×FY 2018: 0.1×FY 2019: 0.1×FY 2020: 0.2×FY 2021: 0.1×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 0.1×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA -0.1×
FY 2016: -0.0×FY 2017: -0.0×FY 2018: -0.3×FY 2019: -0.3×FY 2020: 0.1×FY 2021: -0.0×FY 2022: -0.1×FY 2023: -0.0×FY 2024: 0.0×FY 2025: -0.1×
FY 2016 5y median -0.0× FY 2025
Interest Coverage 81.7×
FY 2016: 185×FY 2017: 82.8×FY 2018: 89.9×FY 2019: 73.2×FY 2020: 62.9×FY 2021: 156×FY 2022: 90.7×FY 2023: 59.6×FY 2024: 72.3×FY 2025: 81.7×
FY 2016 5y median 81.7× FY 2025

Dividends

Dividend Yield 0.5%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.5%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 8.2%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 8.2%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31